State of Wisconsin Investment Board
NGM

State of Wisconsin Investment Board’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

State of Wisconsin Investment Board’s Portfolio NGM Stock Details NGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-69,000
Closed -$59.3K – 2479
2023
Q4 		$59.3K Sell
69,000
-48,700
-41% -$42.8K ﹤0.01% 2295
2023
Q3 		$126K Sell
117,700
-47,968
-29% -$99.3K ﹤0.01% 2336
2023
Q2 		$429K Buy
165,668
+21,145
+15% +$75.4K ﹤0.01% 1875
2023
Q1 		$590K Sell
144,523
-8,695
-6% -$40.2K ﹤0.01% 1795
2022
Q4 		$769K Buy
153,218
+122,235
+395% +$766K ﹤0.01% 1657
2022
Q3 		$405K Sell
30,983
-1,377
-4% -$20.9K ﹤0.01% 2071
2022
Q2 		$415K Sell
32,360
-1,140
-3% -$15.8K ﹤0.01% 2171
2022
Q1 		$511K Hold
33,500
– – ﹤0.01% 1859
2021
Q4 		$593K Hold
33,500
– – ﹤0.01% 1627
2021
Q3 		$704K Hold
33,500
– – ﹤0.01% 1571
2021
Q2 		$661K Hold
33,500
– – ﹤0.01% 1600
2021
Q1 		$974K Hold
33,500
– – ﹤0.01% 1370
2020
Q4 		$1.01M Sell
33,500
-4,200
-11% -$91.9K ﹤0.01% 1324
2020
Q3 		$600K Hold
37,700
– – ﹤0.01% 1417
2020
Q2 		$744K Hold
37,700
– – ﹤0.01% 1312
2020
Q1 		$465K Buy
37,700
+27,600
+273% +$451K ﹤0.01% 1369
2019
Q4 		$187K Hold
10,100
– – ﹤0.01% 1586
2019
Q3 		$140K Buy
+10,100
New +$152K ﹤0.01% 1522

Other funds holding NGM

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State of Wisconsin Investment Board's NGM Position: Q1 2024 in Review

State of Wisconsin Investment Board sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q1 2024, closing a stake of 69,000 shares — an estimated $59.3K sold.

State of Wisconsin Investment Board first reported a position in NGM in Q3 2019 and held it in 18 quarters. The position peaked at $1.01M in Q4 2020. 75 funds tracked by Wall St. Rank hold NGM as of Q1 2024.

  • State of Wisconsin Investment Board reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 69,000 NGM Biopharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $59.3K.
  • State of Wisconsin Investment Board first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q3 2019 and held it in 18 quarters.
  • State of Wisconsin Investment Board's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $1.01M in Q4 2020.
  • 75 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2024, filed 14 May 2024.